Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Colostrum Oropharyngeal Immunotherapy on Postnatal Growth in Preterm Infants Based on Early Gut Microbiota-Host Interaction Patterns: A Protocol for a Randomized Controlled Trial

NCT07082881 is registered in ClinicalTrials.gov with Suqian First Hospital as lead sponsor.

NCT NCT07082881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07082881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Colostrum Oropharyngeal Immunotherapy on Postnatal Growth in Preterm Infants Based on Early Gut Microbiota-Host Interaction Patterns: A Protocol for a Randomized Controlled Trial
Lead sponsor
Suqian First Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
September 30, 2028
Enrollment
220 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

growth failure, microbiota, preterm birth